Dai Tianxing, Ye Linsen, Yu Haoyuan, Li Kun, Li Jing, Liu Rongqiang, Lu Xu, Deng Mingbin, Li Rong, Liu Wei, Yang Yang, Wang Guoying
Department of Hepatic Surgery and Liver Transplant Program, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, People's Republic of China.
Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510630, People's Republic of China.
J Hepatocell Carcinoma. 2021 Aug 30;8:997-1021. doi: 10.2147/JHC.S323743. eCollection 2021.
The aldo-keto reductase (AKR) superfamily members have been proposed with multiple roles in various tumors. Here, a comprehensive analysis on the integral role of AKR genes was conducted to evaluate the expression profile, regulation network, and prognostic significance in hepatocellular carcinoma (HCC).
Transcriptome datasets of HCC were obtained from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus. Univariate and multivariate Cox regression analyses were used to build a novel risk score model, and then were further used to identify independent prognostic factors for overall survival (OS) of HCC. A prognostic nomogram was developed and validated. The expression of these critical AKR members was also evaluated by quantitative real-time polymerase chain reaction and immunohistochemistry in HCC specimens.
Eight differentially expressed AKR genes were identified in HCC. The dysregulation of most AKR genes was negatively correlated with DNA methylation, and a regulation network with transcription factors (TFs) was also established. Then, three critical AKR genes (, and ) were screened out to build a novel risk score model. Worse OS was observed in high-risk patients. Besides, a prognostic nomogram based on the model was further established and validated in both the TCGA and GSE14520 cohorts, which showed superior performance in predicting the OS of HCC patients. Notably, close correlations were identified between the risk score and tumor immune microenvironment, somatic mutation profiles, and drug susceptibilities of HCC. Finally, the upregulated AKR1B10 and downregulated AKR1D1 and AKR7A3 were further verified in HCC tumor and adjacent tissues from our institution.
The dysregulated AKR genes could be mediated by DNA methylation and TFs in HCC. The risk model established with superior prognostic performance further suggested the significant role of AKR genes involved in the progression of HCC.
醛酮还原酶(AKR)超家族成员在多种肿瘤中具有多种作用。在此,对AKR基因的整体作用进行了全面分析,以评估其在肝细胞癌(HCC)中的表达谱、调控网络和预后意义。
从癌症基因组图谱(TCGA)和基因表达综合数据库获取HCC的转录组数据集。采用单因素和多因素Cox回归分析构建新的风险评分模型,进而用于识别HCC总生存期(OS)的独立预后因素。开发并验证了预后列线图。还通过定量实时聚合酶链反应和免疫组化在HCC标本中评估了这些关键AKR成员的表达。
在HCC中鉴定出8个差异表达的AKR基因。大多数AKR基因的失调与DNA甲基化呈负相关,还建立了与转录因子(TFs)的调控网络。然后,筛选出3个关键的AKR基因( 、 和 )构建新的风险评分模型。在高风险患者中观察到较差的OS。此外,基于该模型的预后列线图在TCGA和GSE14520队列中进一步建立并验证,其在预测HCC患者的OS方面表现出卓越性能。值得注意的是,在HCC的风险评分与肿瘤免疫微环境、体细胞突变谱和药物敏感性之间发现了密切相关性。最后,在本机构的HCC肿瘤及癌旁组织中进一步验证了AKR1B10的上调以及AKR1D1和AKR7A3的下调。
AKR基因失调在HCC中可能由DNA甲基化和TFs介导。建立的具有卓越预后性能的风险模型进一步表明AKR基因在HCC进展中具有重要作用。